GSK3A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.729400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.262400E-01
Normal-vs-Stage2
2.973200E-01
Normal-vs-Stage3
8.224200E-01
Normal-vs-Stage4
3.850000E-02
Stage1-vs-Stage2
9.544000E-01
Stage1-vs-Stage3
5.387600E-01
Stage1-vs-Stage4
4.537200E-01
Stage2-vs-Stage3
4.031600E-01
Stage2-vs-Stage4
6.232000E-01
Stage3-vs-Stage4
4.061800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.823600E-03
Normal-vs-AfricanAmerican
8.374300E-02
Normal-vs-Asian
6.108000E-02
Caucasian-vs-AfricanAmerican
3.486000E-01
Caucasian-vs-Asian
3.801600E-01
AfricanAmerican-vs-Asian
7.803800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.775700E-04
Normal-vs-Female
3.106400E-01
Male-vs-Female
5.439200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.310600E-01
Normal-vs-Age(41-60Yrs)
1.024830E-01
Normal-vs-Age(61-80Yrs)
4.723200E-03
Normal-vs-Age(81-100Yrs)
2.843200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.809000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.444400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.332000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.024090E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.816900E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.781180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.548000E-01
Normal-vs-Daily Drinker
1.923050E-03
Normal-vs-Weekly Drinker
2.019000E-01
Normal-vs-Occasional Drinker
1.064110E-03
Normal-vs-Social Drinker
3.450200E-01
Non Drinker-vs-Daily Drinker
7.360900E-03
Non Drinker-vs-Weekly Drinker
5.810300E-02
Non Drinker-vs-Occasional Drinker
2.059400E-03
Non Drinker-vs-Social Drinker
1.312250E-01
Daily Drinker-vs-Weekly Drinker
5.217600E-01
Daily Drinker-vs-Occasional Drinker
6.090800E-01
Daily Drinker-vs-Social Drinker
3.485200E-01
Weekly Drinker-vs-Occasional Drinker
2.636400E-01
Weekly Drinker-vs-Social Drinker
7.463800E-01
Occasional Drinker-vs-Social Drinker
1.673230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.335400E-01
Normal-vs-Grade 2
6.347400E-01
Normal-vs-Grade 3
6.173200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.003800E-01
Grade 1-vs-Grade 3
8.762000E-01
Grade 1-vs-Grade 4
2.335400E-01
Grade 2-vs-Grade 3
6.374400E-01
Grade 2-vs-Grade 4
6.347400E-01
Grade 3-vs-Grade 4
6.173200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.353000E-01
Normal-vs-NonDiabetic
1.902170E-01
Diabetic-vs-NonDiabetic
7.122000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.498770E-01
Normal-vs-NoPancreatitis
2.142500E-03
Pancreatitis-vs-NoPancreatitis
6.047200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.558760E-01
Normal-vs-N1
3.378600E-03
N0-vs-N1
2.133200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.019790E-01
Normal-vs-TP53-NonMutant
5.746800E-01
TP53-Mutant-vs-TP53-NonMutant
2.963400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
